IVIXF (Invion) Equity Investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IVIXF Invion Ltd IVIXF
16 GF Score
Price $0.04
! 8 Warning Signs
View Full Analysis

What is Invion Equity Investments?

Equity Investments only applies to insurance companies.

IVIXF
16GF Score
Invion Ltd IVIXF
Equity Investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Invion Business Description

Other Exchanges 7C8:GermanyIVX:Australia
Address 692 High Street, East Kew, VIC, AUS, 3102
Invion Ltd is an Australian clinical-stage life-science company focused on developing photodynamic therapy (PDT) treatments. Its core technology, Photosoft, is a photosensitiser activated by light to destroy cancer cells and pathogens. Invion holds a perpetual, exclusive, worldwide licence to Photosoft, giving it rights to develop, manufacture, market, distribute, sub-license and commercialise the technology across a portfolio of agreed indications in both human and animal health. The company is advancing Photosoft through clinical trials for a range of cancers and infectious diseases, targeting areas of unmet medical need. As a clinical-stage business, Invion does not yet generate product revenue; its activities are funded through capital raising and it operates as a single reporting segment. Its focus is on progressing its pipeline toward regulatory approval and commercialisation, potentially through partnerships or licensing arrangements with larger pharmaceutical or animal-health companies.
16GF Score

Get the complete analysis for IVIXF

Equity Investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.04
Price